We are live on
!
Find out more
HSA
HBK Sorce Advisory Portfolio holdings
AUM
$5.27B
1-Year Est. Return
19.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.27%
1 Year Est. Return
+19.34%
3 Year Est. Return
+58.25%
5 Year Est. Return
+61.05%
10 Year Est. Return
+218.37%
AUM
$3.99B
AUM Growth
+$294M
(+7.9%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
67.8%
Holding
657
New
65
Increased
256
Reduced
267
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Core Bond ETF
VCRB
|
+$33.3M |
| 2 |
Dimensional US Large Cap Vector ETF
DFVX
|
+$13.2M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$13.1M |
| 4 |
VCRM
Vanguard Core Tax-Exempt Bond ETF
VCRM
|
+$10.9M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$3.36M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$3.3M |
| 3 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$3.23M |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$2.94M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
+$1.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.63% |
| 2 | Financials | 3.55% |
| 3 | Industrials | 2.11% |
| 4 | Communication Services | 2.02% |
| 5 | Healthcare | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Aurora
AUR
$13.8B
| $58.4K | ﹤0.01% |
10,635
-1,126
| -10% | -$6.61K |
|
|
RC
602
Ready Capital
RC
$308M
| $57.2K | ﹤0.01% |
16,925
+374
| +2% | +$1.58K |
|
603
Transocean
RIG
$5.82B
| $54K | ﹤0.01% |
16,308
+174
| +1% | +$525 |
|
604
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $53.5K | ﹤0.01% |
+101,600
| New | +$65.1M |
|
605
Lloyds Banking Group
LYG
$91.3B
| $52.4K | ﹤0.01% |
11,534
+1,185
| +11% | +$5.18K |
|
606
Nuvation Bio
NUVB
$2.32B
| $42.1K | ﹤0.01% |
+11,162
| New | +$30.4K |
|
607
Gevo
GEVO
$382M
| $42K | ﹤0.01% |
16,205
| – | – |
|
608
SES AI
SES
$208M
| $39.7K | ﹤0.01% |
11,210
-68
| -0.6% | -$81 |
|
609
Caribou Biosciences
CRBU
$164M
| $35.1K | ﹤0.01% |
12,344
| – | – |
|
610
Nordic American Tanker
NAT
$1.37B
| $33.6K | ﹤0.01% |
+10,309
| New | +$30.4K |
|
611
Neumora Therapeutics
NMRA
$302M
| $31K | ﹤0.01% |
16,843
+611
| +4% | +$988 |
|
612
Iovance Biotherapeutics
IOVA
$2.87B
| $31K | ﹤0.01% |
13,828
+2,198
| +19% | +$5.19K |
|
|
VXRT
613
DELISTED
Vaxart
VXRT
| $26.2K | ﹤0.01% |
75,118
| – | – |
|
614
Werewolf Therapeutics
HOWL
$19.3M
| $23.3K | ﹤0.01% |
13,227
| – | – |
|
615
Opko Health
OPK
$1.02B
| $20.6K | ﹤0.01% |
13,527
+2,470
| +22% | +$3.39K |
|
616
Lexicon Pharmaceuticals
LXRX
$1.1B
| $18K | ﹤0.01% |
11,786
| – | – |
|
617
Fate Therapeutics
FATE
$326M
| $17.8K | ﹤0.01% |
11,620
-509
| -4% | -$549 |
|
618
Commercial Vehicle Group
CVGI
$147M
| $16.4K | ﹤0.01% |
10,459
-39,000
| -79% | -$71.3K |
|
619
Heron Therapeutics
HRTX
$92.9M
| $13.5K | ﹤0.01% |
+10,000
| New | +$15.9K |
|
|
SACH
620
Sachem Capital Corp
SACH
$39.8M
| $13.2K | ﹤0.01% |
11,749
| – | – |
|
|
621
CALL
Aurora
AUR
$13.8B
| $11.2K | ﹤0.01% |
+10,000
| New | +$58.7K |
|
|
AEVA
622
Aeva Technologies
AEVA
$1.86B
| – | – |
-7,330
| Closed | -$277K |
|
623
Alphatec Holdings
ATEC
$1.44B
| – | – |
-20,430
| Closed | -$227K |
|
|
BRDG
624
DELISTED
Bridge Investment Group
BRDG
| – | – |
-21,307
| Closed | -$213K |
|
625
CF Industries
CF
$17.3B
| – | – |
-2,236
| Closed | -$206K |
|
Similar funds
FMWA
DRZID
WL
SDIC
DDC
KACA
DPL
AUB
HBK Sorce Advisory's Q3 2025 Portfolio in Review
As of Q3 2025, HBK Sorce Advisory held 657 positions worth $3.99B, up 7.9% from $3.7B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
HBK Sorce Advisory deployed $144M of net new capital in Q3 2025, opening 65 new positions and adding to 256 existing holdings. Its largest new stake was Vanguard Core Tax-Exempt Bond ETF: 148,170 shares worth $11.2M.
By sector, the portfolio is most concentrated in Technology at 6.6% of assets, up from 6.3% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $3.36M trimmed.
- HBK Sorce Advisory's largest Q3 2025 buy was Vanguard Core Tax-Exempt Bond ETF: 148,170 shares worth $11.2M.
- HBK Sorce Advisory added most to Vanguard Core Bond ETF in Q3 2025, an estimated $33.3M increase.
- HBK Sorce Advisory's biggest Q3 2025 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $3.36M.
- HBK Sorce Advisory fully exited Verona Pharma in Q3 2025, selling an estimated $2.94M.
- HBK Sorce Advisory's ten largest holdings make up 68% of its $3.99B portfolio in Q3 2025.
- HBK Sorce Advisory opened 65 new positions and closed 31 in Q3 2025.
- HBK Sorce Advisory's portfolio value rose 7.9% quarter-over-quarter to $3.99B.
Based on HBK Sorce Advisory's 13F filing for Q3 2025, filed 14 Oct 2025.